2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Healthy Participant Study: new trials by email Literature Review of Healthy Participant Study trials Research Report on Healthy Participant Study
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants QRL-101, Placebo - Healthy Participant Study | Phase 1 | Completed | QurAlis Corporation | 48 | 2026-02-02 | 2026-10-06 |
| This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects BEAM-103, Placebo Comparator - Healthy Subjects, Healthy Participant Study | Phase 1 | Recruiting | Beam Therapeutics Inc. | 30 | 2025-10-27 | 2025-12-26 |
| RE104 Radiolabeled Mass Balance (hAME) Study 2-[14C]-RE104 for Injection - Healthy Participant Study | Phase 1 | Completed | Reunion Neuroscience Inc | 8 | 2025-08-19 | 2025-11-20 |
Injections (1)
Beam Therapeutics Inc. (1) · QurAlis Corporation (1) · Reunion Neuroscience Inc (1)
Netherlands (1) · United Kingdom (1) · United States (1)
Mark Pollack, Chief Medical Officer (1)
2025 (1)